Less than a year after Leaps by Bayer invested in biomolecular condensates company Dewpoint, the corporate VC’s parent company has struck an option deal that broadens its access to the start-up’s technology…
Full articleMonths after investment, Bayer strikes option deal with Dewpoint in CV, women’s health
November 14th, 2019 | Biocentury